Last reviewed · How we verify
Rabies mRNA vaccine CV7202 — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Rabies mRNA vaccine CV7202 (Rabies mRNA vaccine CV7202) — CureVac.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Rabies mRNA vaccine CV7202 TARGET | Rabies mRNA vaccine CV7202 | CureVac | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Rabies mRNA vaccine CV7202 CI watch — RSS
- Rabies mRNA vaccine CV7202 CI watch — Atom
- Rabies mRNA vaccine CV7202 CI watch — JSON
- Rabies mRNA vaccine CV7202 alone — RSS
Cite this brief
Drug Landscape (2026). Rabies mRNA vaccine CV7202 — Competitive Intelligence Brief. https://druglandscape.com/ci/rabies-mrna-vaccine-cv7202. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab